β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.

COVID-19 SARS-CoV-2 beta-caryophyllene immunomodulators natural products

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 31 07 2020
accepted: 04 02 2021
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 1 6 2021
Statut: epublish

Résumé

Coronavirus disease (COVID-19), caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic and presents a public health emergency. It has affected millions of people and continues to affect more, despite tremendous social preventive measures. Identifying candidate drugs for the prevention and treatment of COVID-19 is crucial. The pathogenesis and the complications with advanced infection mainly involve an immune-inflammatory cascade. Therefore, therapeutic strategy relies on suppressing infectivity and inflammation, along with immune modulation. One of the most promising therapeutic targets for the modulation of immune-inflammatory responses is the endocannabinoid system, particularly the activation of cannabinoid type 2 receptors (CB2R), a G-protein coupled receptor which mediates the anti-inflammatory properties by modulating numerous signaling pathways. To pharmacologically activate the CB2 receptors, a naturally occurring cannabinoid ligand, beta-caryophyllene (BCP), received attention due to its potent anti-inflammatory, antiviral, and immunomodulatory properties. BCP is recognized as a full selective functional agonist on CB2 receptors and produces therapeutic effects by activating CB2 and the nuclear receptors, peroxisome proliferator-activated receptors (PPARs). BCP is regarded as the first dietary cannabinoid with abundant presence across cannabis and non-cannabis plants, including spices and other edible plants. BCP showed tissue protective properties and favorably modulates numerous signaling pathways and inhibits inflammatory mediators, including cytokines, chemokines, adhesion molecules, prostanoids, and eicosanoids. Based on its pharmacological properties, molecular mechanisms, and the therapeutic potential of BCP as an immunomodulator, anti-inflammatory, organ-protective, and antiviral, we hypothesize that BCP could be a promising therapeutic and/or preventive candidate to target the triad of infection, immunity, and inflammation in COVID-19. In line with numerous studies that proposed the potential of cannabinoids in COVID-19, BCP may be a novel candidate compound for pharmaceutical and nutraceutical development due to its unique functional receptor selectivity, wide availability and accessibility, dietary bioavailability, nonpsychoactivity, and negligible toxicity along with druggable properties, including favorable pharmacokinetic and physicochemical properties. Based on reasonable pharmacological mechanisms and therapeutic properties, we speculate that BCP has potential to be investigated against COVID-19 and will inspire further preclinical and clinical studies.

Identifiants

pubmed: 34054510
doi: 10.3389/fphar.2021.590201
pii: 590201
pmc: PMC8163236
doi:

Types de publication

Journal Article

Langues

eng

Pagination

590201

Informations de copyright

Copyright © 2021 Jha, Sharma, Hashiesh, Arunachalam, Meeran, Javed, Patil, Goyal and Ojha.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mediators Inflamm. 2014;2014:978678
pubmed: 24803745
Pharm Biol. 2015 May;53(5):682-8
pubmed: 25431185
Aging (Albany NY). 2020 Nov 22;12(22):22425-22444
pubmed: 33221759
Int J Physiol Pathophysiol Pharmacol. 2018 Dec 25;10(6):163-171
pubmed: 30697363
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
Biochem Pharmacol. 2019 Jan;159:154-171
pubmed: 30529211
Sex Med. 2020 Sep;8(3):525-531
pubmed: 32561330
J Clin Biochem Nutr. 2018 May;62(3):230-237
pubmed: 29892161
Environ Toxicol Pharmacol. 2016 Mar;42:55-62
pubmed: 26773363
Pathogens. 2020 Jun 12;9(6):
pubmed: 32545549
Int J Mol Sci. 2020 Jun 30;21(13):
pubmed: 32629817
Eur J Pharmacol. 2015 Mar 5;750:141-50
pubmed: 25622554
Eur J Pharmacol. 2015 Oct 5;764:613-621
pubmed: 26254779
Curr Drug Metab. 2018;19(3):236-263
pubmed: 29380697
Gut. 2020 Aug;69(8):1543-1544
pubmed: 32312790
Cell. 2008 Apr 18;133(2):235-49
pubmed: 18423196
Brain Behav Immun. 2020 Jul;87:120-121
pubmed: 32360437
Life Sci. 2007 Feb 13;80(10):932-9
pubmed: 17188718
Chem Biol Interact. 2017 May 25;270:9-14
pubmed: 28411027
Chem Biol Interact. 2019 Jan 5;297:16-24
pubmed: 30343038
Arch Iran Med. 2020 Apr 01;23(4):268-271
pubmed: 32271601
J Cardiovasc Pharmacol. 2017 Feb;69(2):79-85
pubmed: 27798416
Front Pharmacol. 2020 Nov 25;11:571434
pubmed: 33324206
Pharmacology. 2014;94(1-2):1-12
pubmed: 25171128
Gac Med Mex. 2020;156(3):257
pubmed: 32539010
Int Immunopharmacol. 2020 Jan;78:106007
pubmed: 31806570
Naunyn Schmiedebergs Arch Pharmacol. 2017 Feb;390(2):215-223
pubmed: 27913825
Nat Prod Commun. 2011 Jul;6(7):1031-4
pubmed: 21834251
Viral Immunol. 2010 Aug;23(4):343-52
pubmed: 20712478
PLoS One. 2017 Feb 16;12(2):e0172322
pubmed: 28207861
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L277-L288
pubmed: 32551862
J Toxicol Pathol. 2017 Oct;30(4):263-273
pubmed: 29097836
Planta Med. 2020 Jul;86(10):659-664
pubmed: 32434254
Sci Rep. 2021 Jan 14;11(1):1462
pubmed: 33446817
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Biomed Pharmacother. 2019 Apr;112:108693
pubmed: 30798128
Molecules. 2020 Apr 29;25(9):
pubmed: 32365556
Antivir Chem Chemother. 2005;16(4):247-51
pubmed: 16130522
Inflamm Res. 2016 Nov;65(11):869-879
pubmed: 27379721
Mol Cell Biochem. 2016 Jul;418(1-2):59-70
pubmed: 27316720
Planta Med. 2012 May;78(7):681-5
pubmed: 22411723
Br J Pharmacol. 2020 Nov;177(21):4967-4970
pubmed: 32519753
Neuropharmacology. 2017 Oct;125:207-219
pubmed: 28729222
J Agric Food Chem. 2004 Oct 6;52(20):6326-9
pubmed: 15453708
Can J Physiol Pharmacol. 2016 Jul;94(7):739-44
pubmed: 27124106
Biomedicines. 2020 Jun 17;8(6):
pubmed: 32560286
Curr Pharm Des. 2018 Dec 8;24(29):3440-3453
pubmed: 30207226
PLoS One. 2012;7(3):e33961
pubmed: 22448282
Br J Pharmacol. 2008 Jan;153(2):347-57
pubmed: 17994109
BMC Complement Altern Med. 2014 Mar 11;14:94
pubmed: 24612782
Planta Med. 1996 Oct;62(5):469-70
pubmed: 9005452
Molecules. 2019 May 19;24(10):
pubmed: 31109132
Nat Prod Commun. 2010 Sep;5(9):1365-8
pubmed: 20922992
Am J Pathol. 2013 Mar;182(3):928-39
pubmed: 23414569
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Minerva Med. 2018 Oct;109(5):358-362
pubmed: 30338679
Chem Biol Interact. 2019 May 1;304:158-167
pubmed: 30836069
Exp Toxicol Pathol. 2016 Sep;68(8):451-61
pubmed: 27449700
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Handb Exp Pharmacol. 2015;231:185-211
pubmed: 26408161
J Cell Mol Med. 2020 Nov;24(21):12869-12872
pubmed: 33058425
Pharm Biol. 2017 Dec;55(1):1553-1560
pubmed: 28385055
Arch Physiol Biochem. 2019 Dec;125(5):404-413
pubmed: 29884068
Life Sci. 2019 Nov 15;237:116915
pubmed: 31610207
J Ethnopharmacol. 1988 Jan;22(1):101-9
pubmed: 3352280
Molecules. 2012 Oct 11;17(10):11965-77
pubmed: 23060288
Life Sci. 2019 Feb 15;219:40-73
pubmed: 30620895
Mol Med Rep. 2015 Apr;11(4):2852-60
pubmed: 25522803
J Biomol Struct Dyn. 2020 Nov 5;:1-18
pubmed: 33150860
Int J Biomed Sci. 2016 Jun;12(2):71-8
pubmed: 27493593
PLoS One. 2019 Dec 16;14(12):e0216104
pubmed: 31841509
Clin Chem Lab Med. 2020 Jul 28;58(8):1365-1371
pubmed: 32441666
Med Hypotheses. 2018 Jan;110:68-70
pubmed: 29317072
J Sci Food Agric. 2019 Oct;99(13):5870-5880
pubmed: 31206687
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3168-74
pubmed: 24856059
Nat Prod Res. 2010 Dec;24(20):1933-8
pubmed: 21108120
J Ethnopharmacol. 2019 Mar 1;231:325-336
pubmed: 30445104
J Oleo Sci. 2017 Jan 1;66(1):51-63
pubmed: 27928138
Phytomedicine. 2008 Jan;15(1-2):79-83
pubmed: 17482448
Expert Rev Anti Infect Ther. 2020 Sep;18(9):843-847
pubmed: 32419524
Fitoterapia. 2019 Oct;138:104266
pubmed: 31302251
Toxicol Appl Pharmacol. 2017 Aug 15;329:326-333
pubmed: 28624443
Exp Parasitol. 2017 Apr;175:59-67
pubmed: 28189487
Clin Hemorheol Microcirc. 2015;61(2):237-49
pubmed: 26410875
Eur J Pharmacol. 2000 May 19;396(2-3):141-9
pubmed: 10822068
J Enzyme Inhib Med Chem. 2017 Dec;32(1):504-515
pubmed: 28112000
J Biol Chem. 2016 Sep 9;291(37):19517-31
pubmed: 27474745
J Med Chem. 2007 Aug 23;50(17):4087-95
pubmed: 17663539
Br Poult Sci. 2018 Aug;59(4):389-395
pubmed: 29768944
Front Pharmacol. 2020 Nov 06;11:589438
pubmed: 33240092
Adicciones. 2020 Jul 01;32(3):167-172
pubmed: 32717094
Virulence. 2018 Jan 1;9(1):217-230
pubmed: 28992427
Phytomedicine. 2012 Oct 15;19(13):1185-90
pubmed: 22951389
Liver Int. 2020 Oct;40(10):2568
pubmed: 32306495
BMC Complement Altern Med. 2019 Jun 10;19(1):123
pubmed: 31182095
Phytomedicine. 2010 Aug;17(10):721-5
pubmed: 20171859
Phytomedicine. 2004 Nov;11(7-8):657-61
pubmed: 15636181
Exp Ther Med. 2019 May;17(5):4312-4318
pubmed: 31007758
J Neuroimmune Pharmacol. 2012 Dec;7(4):843-55
pubmed: 21789506
Curr Mol Med. 2020;20(8):643-652
pubmed: 32065089
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
J Chin Med Assoc. 2020 Jun;83(6):521-523
pubmed: 32243269
Comp Immunol Microbiol Infect Dis. 2020 Dec;73:101547
pubmed: 32919182
Int J Mol Sci. 2020 May 05;21(9):
pubmed: 32380787
Neurochem Res. 2017 May;42(5):1459-1469
pubmed: 28236211
Food Chem. 2013 Nov 15;141(2):1104-13
pubmed: 23790892
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Complement Ther Clin Pract. 2018 Nov;33:170-176
pubmed: 30396617
Life Sci. 2019 Sep 15;233:116750
pubmed: 31408659
J Sci Food Agric. 2016 Jul;96(9):3195-201
pubmed: 26467601
Acta Pharm. 2019 Mar 1;69(1):121-128
pubmed: 31259712
Mediators Inflamm. 2012;2012:824093
pubmed: 22577257
Int J Mol Sci. 2020 May 12;21(10):
pubmed: 32408699
Biochem Biophys Res Commun. 2013 Jul 5;436(3):377-81
pubmed: 23747418
Genomics. 2020 Nov;112(6):4486-4504
pubmed: 32771622
Cytokine Growth Factor Rev. 2020 Jun;53:63-65
pubmed: 32467020
Nat Prod Res. 2015;29(6):582-5
pubmed: 25174508
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872332
J Neurochem. 2016 Dec;139(5):757-768
pubmed: 27565895
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512
pubmed: 32482366
Nature. 1993 Sep 2;365(6441):61-5
pubmed: 7689702
Front Neurosci. 2017 Oct 26;11:583
pubmed: 29123466
Nutrients. 2019 Nov 15;11(11):
pubmed: 31731718
Toxicol Rep. 2020 Jun 18;7:768-771
pubmed: 32632359
J Microbiol. 2018 Sep;56(9):683-689
pubmed: 30141161
Behav Brain Res. 2019 Oct 17;372:112012
pubmed: 31173795
Environ Toxicol. 2016 Nov;31(11):1319-1328
pubmed: 25728712
Allergy. 2020 Jul;75(7):1699-1709
pubmed: 32196678
Br J Pharmacol. 2020 Nov;177(21):4813-4824
pubmed: 32329520
Virol J. 2017 May 25;14(1):96
pubmed: 28545573
Front Neurosci. 2016 Aug 02;10:321
pubmed: 27531971
J Ethnopharmacol. 2014 Aug 8;155(1):485-94
pubmed: 24892832
Evid Based Complement Alternat Med. 2020 Jun 3;2020:8746137
pubmed: 32595747
Vaccines (Basel). 2020 Apr 14;8(2):
pubmed: 32295153
Neurochem Res. 2016 Jun;41(6):1291-304
pubmed: 26801169
Antimicrob Agents Chemother. 2007 May;51(5):1859-62
pubmed: 17353250
Br J Pharmacol. 2011 Aug;163(7):1344-64
pubmed: 21749363
J Pharm Anal. 2020 Aug;10(4):313-319
pubmed: 32296570
J Enzyme Inhib Med Chem. 2014 Feb;29(1):59-63
pubmed: 23323951
Toxicol Rep. 2015 Jul 26;2:1039-1045
pubmed: 28962446
Behav Brain Res. 2020 Feb 17;380:112439
pubmed: 31862467
PLoS One. 2009 Jul 29;4(7):e6409
pubmed: 19641602
Toxicol Rep. 2018 Mar 21;5:480-488
pubmed: 29854619
J Altern Complement Med. 2020 Jun;26(6):444-448
pubmed: 32380847
Sci Rep. 2020 Oct 19;10(1):17699
pubmed: 33077836
Inflammopharmacology. 2020 Oct;28(5):1153-1161
pubmed: 32803479
Neuroimmunomodulation. 2017;24(4-5):183-199
pubmed: 29151103
Neurosci Res. 2020 Sep;158:1-5
pubmed: 32628969
Commun Integr Biol. 2008;1(1):26-8
pubmed: 19704783
J Leukoc Biol. 2016 Apr;99(4):531-40
pubmed: 26467187
Ann Clin Microbiol Antimicrob. 2020 Sep 2;19(1):40
pubmed: 32878641
Travel Med Infect Dis. 2020 Sep - Oct;37:101755
pubmed: 32479816
Curr Pharm Des. 2016;22(21):3237-64
pubmed: 26965491
Mol Clin Oncol. 2015 Jul;3(4):825-828
pubmed: 26171189
Molecules. 2015 May 21;20(5):9380-92
pubmed: 26007189
Int Immunopharmacol. 2020 Jan;78:105978
pubmed: 31767546
Liver Int. 2020 Jun;40(6):1278-1281
pubmed: 32251539
Cannabis Cannabinoid Res. 2020 Sep 02;5(3):197-201
pubmed: 32923657
Mol Nutr Food Res. 2016 Oct;60(10):2228-2242
pubmed: 27234712
Phytomedicine. 2018 Mar 1;41:82-95
pubmed: 29519324
Prev Nutr Food Sci. 2013 Jun;18(2):111-6
pubmed: 24471119
Front Immunol. 2020 Jun 16;11:1441
pubmed: 32612615
FASEB J. 2019 May;33(5):6154-6167
pubmed: 30799631
Inflamm Allergy Drug Targets. 2013 Dec;12(6):378-84
pubmed: 24266685
Free Radic Biol Med. 2012 Apr 15;52(8):1325-33
pubmed: 22326488
J Virol. 2019 Apr 17;93(9):
pubmed: 30787149
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340197
Int J Mol Sci. 2020 Jul 06;21(13):
pubmed: 32640747
Pharmacol Rep. 2020 Dec;72(6):1479-1508
pubmed: 32889701
Molecules. 2015 Nov 16;20(11):20426-33
pubmed: 26580590
J Ethnopharmacol. 2012 Jan 31;139(2):668-71
pubmed: 22193174
J Med Food. 2020 May;23(5):515-522
pubmed: 31663807
Evid Based Complement Alternat Med. 2011;2011:253643
pubmed: 20008902
Front Plant Sci. 2020 Oct 15;11:568890
pubmed: 33178237
J Food Biochem. 2020 May;44(5):e13190
pubmed: 32155675
Antioxidants (Basel). 2020 Jun 12;9(6):
pubmed: 32545518
Eur J Pharmacol. 2014 Nov 5;742:118-24
pubmed: 25179573
Molecules. 2019 Dec 27;25(1):
pubmed: 31892132
Int J Mol Sci. 2017 Apr 01;18(4):
pubmed: 28368293
Medicina (Kaunas). 2019 May 23;55(5):
pubmed: 31126036
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
J Ethnopharmacol. 2016 Dec 24;194:698-705
pubmed: 27769947
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Eur J Pharm Sci. 2020 May 30;148:105318
pubmed: 32205230
Front Pharmacol. 2017 Jan 19;8:2
pubmed: 28154534
Phytother Res. 2003 Nov;17(9):1073-5
pubmed: 14595590
Crit Care Med. 2017 Feb;45(2):253-262
pubmed: 27632674
Clin Med (Lond). 2020 Sep;20(5):e146-e147
pubmed: 32601125
J Biomol Struct Dyn. 2020 Jul 24;:1-9
pubmed: 32705962
J Clin Med. 2020 Jul 03;9(7):
pubmed: 32635302
Life Sci. 2020 Jun 15;251:117627
pubmed: 32251634
Biomed Pharmacother. 2017 Jul;91:257-264
pubmed: 28463791
Eur J Pharm Biopharm. 2015 Oct;96:152-61
pubmed: 26209123
Eur Neuropsychopharmacol. 2014 Apr;24(4):608-20
pubmed: 24210682
Immunobiology. 2010 Aug;215(8):598-605
pubmed: 19457575
Int J Antimicrob Agents. 2020 Aug;56(2):106024
pubmed: 32450197
Br J Nutr. 2013 Feb 14;109(3):394-401
pubmed: 22717234
Biomed Pharmacother. 2019 Feb;110:145-154
pubmed: 30469079
Front Immunol. 2017 Nov 10;8:1487
pubmed: 29176975
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104
pubmed: 18574142
Adv Pharmacol. 2017;80:169-206
pubmed: 28826534
Viruses. 2018 Jul 26;10(8):
pubmed: 30049972
Mitochondrion. 2020 Sep;54:1-7
pubmed: 32574708
Drug Dev Res. 2021 Feb;82(1):7-11
pubmed: 33190277
Am J Pathol. 2011 Mar;178(3):1153-66
pubmed: 21356367
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2210-8
pubmed: 17660390
J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):1-10
pubmed: 12352144
Front Pharmacol. 2020 Aug 07;11:1189
pubmed: 32848790
Molecules. 2019 Nov 21;24(23):
pubmed: 31766439
J Clin Transl Hepatol. 2020 Mar 28;8(1):18-24
pubmed: 32274342
IUBMB Life. 2017 Jan;69(1):22-29
pubmed: 28026135
Chem Biol Interact. 2016 Feb 5;245:50-8
pubmed: 26748309
Int J Mol Sci. 2020 Mar 25;21(7):
pubmed: 32218156
Korean J Gastroenterol. 2019 Oct 25;74(4):199-204
pubmed: 31650795
Roum Arch Microbiol Immunol. 2012 Apr-Jun;71(2):61-9
pubmed: 23210318
J Virol. 2019 Aug 28;93(18):
pubmed: 31243135
J Basic Clin Physiol Pharmacol. 2019 Dec 25;31(1):
pubmed: 31874099
Nat Prod Bioprospect. 2020 Oct;10(5):297-306
pubmed: 32557405
J Toxicol Sci. 2014;39(6):849-59
pubmed: 25374376
Biomolecules. 2019 Jul 31;9(8):
pubmed: 31370242
Exp Lung Res. 2015;41(7):393-403
pubmed: 26151160
J Oleo Sci. 2014;63(4):373-81
pubmed: 24599102
Int Immunopharmacol. 2019 Dec;77:105923
pubmed: 31711937
J Cell Biochem. 2018 Dec;119(12):10262-10277
pubmed: 30132972
Cell Signal. 2020 May;69:109556
pubmed: 32027949
Exp Gerontol. 2014 Sep;57:81-95
pubmed: 24835194
Biomolecules. 2021 Jan 07;11(1):
pubmed: 33430299
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Food Chem Toxicol. 2019 Feb;124:17-29
pubmed: 30481574
Mutat Res. 2010 Jun 17;699(1-2):23-8
pubmed: 20398787
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Plants (Basel). 2020 Jun 26;9(6):
pubmed: 32604842
Br J Pharmacol. 2016 Jun;173(12):1899-910
pubmed: 27077495
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672
pubmed: 32278065
Molecules. 2017 Mar 13;22(3):
pubmed: 28335395
Front Pharmacol. 2019 Nov 14;10:1347
pubmed: 31798452
Rev Med Virol. 2020 Sep;30(5):e2123
pubmed: 32648313
Int J Biol Macromol. 2021 Jan 31;168:474-485
pubmed: 33290767
Acta Clin Belg. 2019 Apr;74(2):70-74
pubmed: 29694303
J Leukoc Biol. 2013 May;93(5):801-10
pubmed: 23463725
Int Immunopharmacol. 2020 Jul;84:106556
pubmed: 32416450
Bioresour Technol. 2008 Jun;99(9):3908-13
pubmed: 17826984
J Ethnopharmacol. 2020 Apr 24;252:112562
pubmed: 31954197
Molecules. 2015 Jun 26;20(7):11808-29
pubmed: 26132906
Crit Care. 2020 Apr 16;24(1):155
pubmed: 32299479
Front Med. 2020 Apr;14(2):117-125
pubmed: 32318975
Nat Rev Immunol. 2016 Jun;16(6):392-400
pubmed: 27157064
Br J Pharmacol. 2018 Jan;175(2):320-334
pubmed: 28107775
Lipids Health Dis. 2018 Feb 05;17(1):23
pubmed: 29402275
Int J Mol Med. 2016 Dec;38(6):1940-1946
pubmed: 27840942
Curr Med Chem. 2018;25(8):889-907
pubmed: 28393690
Int J Stroke. 2020 Oct;15(7):733-742
pubmed: 32501751

Auteurs

Niraj Kumar Jha (NK)

Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, India.

Charu Sharma (C)

Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Hebaallah Mamdouh Hashiesh (HM)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Seenipandi Arunachalam (S)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Mf Nagoor Meeran (MN)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Hayate Javed (H)

Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Chandragouda R Patil (CR)

Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.

Sameer N Goyal (SN)

Shri Vile Parle Kelvani Mandal's Institute of Pharmacy, Dhule, India.

Shreesh Ojha (S)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Classifications MeSH